Transfer method for specific cellular localization of nucleic acids
AssigneeAvaris AB
InventorsLars Branden, Abdalla J. Mohamed, C. I. Edvard Smith
Life of this patent
Estimating the term…
Loading patent…
AssigneeAvaris AB
InventorsLars Branden, Abdalla J. Mohamed, C. I. Edvard Smith
Estimating the term…
The present invention relates to a novel method of genetic modification, wherein a nucleic acid of interest is transferred across a biological membrane, and/or directed to a specific location within or on a cell, by use of a synthetic transport entity. The transport entity according to the invention is new as such and produced by coupling a functional element (FE), such as a nuclear localization signal (NLS), an antennapedia peptide of a protein comprising both membrane translocation and nuclear transport properties, to a binding element (BE), such as a peptide nucleic acid (PNA), preferably separated by a linker molecule, which combination is then hybridized to a BE target sequence present on a carrier, which also includes the nucleic acid of interest. The present nucleic acid of interest may for example be a gene encoding a peptide, a protein or an RNA, or any other nucleic acid useful in genetic recombination events.
A synthetic transport complex for transferring a nucleic acid of interest across a biological membrane into a cell, wherein the complex is comprised of two or more functional elements (FE), each of which is complexed to a binding element (BE) in the form of a peptide nucleic acid (PNA), and a nucleic acid carrier, which comprises at least two BE target sequences and a nucleic acid of interest in a vector;
A kit comprising components for making a transport entity capable of transferring a nucleic acid of interest across a biological membrane into a cell, which kit comprises at least two binding elements (BE) in the form of a peptide nucleic acid (PNA);
Dependencies are inferred from the claim text.